ArticleInternational journal of hematology2019

Immunoparesis in symptomatic multiple myeloma at diagnosis affects PFS with bortezomib-containing induction therapy, but not ASCT consolidation.

Wen Gao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.